The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-heptylpiperazine-1-carboxamido)phenyl sulfamate ID: ALA4588106
PubChem CID: 155567815
Max Phase: Preclinical
Molecular Formula: C18H30N4O4S
Molecular Weight: 398.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCN1CCN(C(=O)Nc2ccc(OS(N)(=O)=O)cc2)CC1
Standard InChI: InChI=1S/C18H30N4O4S/c1-2-3-4-5-6-11-21-12-14-22(15-13-21)18(23)20-16-7-9-17(10-8-16)26-27(19,24)25/h7-10H,2-6,11-15H2,1H3,(H,20,23)(H2,19,24,25)
Standard InChI Key: HQRCHVYJPWJCHL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
15.4028 -21.6473 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8155 -22.3572 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.2240 -21.6448 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2339 -21.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2327 -22.3595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9408 -22.7685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6505 -22.3590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6476 -21.5364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9390 -21.1311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5247 -22.7675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1093 -22.7664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3538 -21.1251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0630 -21.5310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7692 -21.1198 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0661 -22.3482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4770 -21.5284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1811 -21.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1822 -20.3031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4732 -19.8950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7629 -20.3044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8900 -19.8945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5977 -20.3031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5976 -21.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3054 -21.5289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0131 -21.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7208 -21.5289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4285 -21.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
5 10 1 0
10 2 1 0
2 11 1 0
8 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
14 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
18 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.53Molecular Weight (Monoisotopic): 398.1988AlogP: 2.39#Rotatable Bonds: 9Polar Surface Area: 104.97Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.75CX Basic pKa: 7.63CX LogP: 2.48CX LogD: 2.04Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.62Np Likeness Score: -1.38
References 1. Moi D, Foster PA, Rimmer LG, Jaffri A, Deplano A, Balboni G, Onnis V, Potter BVL.. (2019) Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors., 182 [PMID:31422224 ] [10.1016/j.ejmech.2019.111614 ]